Neuven Life Sciences Private Limited - Company Profile

It is a business services private limited company based in Tirumalagiri, Telangana, India, established in 2023.
2023 Tirumalagiri, Telangana, India Active
Last Updated:
Access Report
About Neuven Life Sciences Private Limited

Neuven Life Sciences Private Limited, a active private limited company, was established on 19 October 2023 in Tirumalagiri, Telangana, India. it holds CIN: U10802TS2023PTC178253. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

Its leadership includes Venkata Suresh Kumar Nukavarapu (Director), Suneela Nukavarapu (Director). Past directors included Nagamadhu Arikatla, Challagundla Venkata Sai Krishna. Its latest AGM occurred on 29 September 2025, with the balance sheet filed on 31 March 2025. It is based at H.No. 2-114/2, Engineers Enclave, Gangaram,, Chandanagar, Hyderabad, Tirumalagiri, Telangana, 500050.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U10802TS2023PTC178253

  • Registration Number

    178253

  • Incorporation Date

    19 October 2023

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Hyderabad

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 2 Year, 3 Months
  • Last Filing with ROC 31 Mar 2025
Company report

Neuven Life Sciences Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Neuven Life Sciences Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Neuven Life Sciences Private Limited?
Current Directors
Name Designation Appointment Date Status
Venkata Suresh Kumar Nukavarapu Director 04 Apr 2025 Current
Suneela Nukavarapu Director 24 Apr 2025 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 25 Apr 2025 Past
Pramod Abcsdd Director 25 Apr 2025 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Neuven Life Sciences.

Enhance accessibility to Neuven Life Sciences's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Neuven Life Sciences revenue growth over time
Neuven Life Sciences profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Neuven Life Sciences?

Unlock access to Neuven Life Sciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Neuven Life Sciences?

Unlock and access historical data on people associated with Neuven Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Neuven Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Neuven Life Sciences's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Neuven Life Sciences
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Neuven Life Sciences Private Limited last Annual general meeting of members was held on 29 Sep 2025 as per latest MCA records. was documented.

  • Director Appointment

    The activity Suneela Nukavarapu was appointed as a Director was appointed as a Director on 24 Apr 2025 & has been associated with this company since 9 months 18 days . was completed.

  • Director Appointment

    Venkata Suresh Kumar Nukavarapu was appointed as a Director was appointed as a Director on 04 Apr 2025 & has been associated with this company since 10 months 7 days . was recorded as a recent event.

  • Balance Sheet

    Progress on Neuven Life Sciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad. was documented.

  • Company Incorporation

    The activity Neuven Life Sciences Private Limited was registered on 19 Oct 2023 with Roc Hyderabad & aged 2 years 3 months as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Neuven Life Sciences Private Limited?

The CIN of Neuven Life Sciences Private Limited is U10802TS2023PTC178253.

Where is Neuven Life Sciences Private Limited headquartered?

Neuven Life Sciences Private Limited is headquartered at H.No. 2-114/2, Engineers Enclave, Gangaram,, Chandanagar, Hyderabad, Tirumalagiri, Telangana, 500050.

When was Neuven Life Sciences Private Limited incorporated?

Neuven Life Sciences Private Limited was incorporated on 19 October 2023.

Who are the current directors of Neuven Life Sciences Private Limited?

The current directors of Neuven Life Sciences Private Limited are

Is Neuven Life Sciences Private Limited a listed company?

Neuven Life Sciences Private Limited is unlisted.

What is the capital structure of Neuven Life Sciences Private Limited?

The authorized capital of Neuven Life Sciences Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available